World's First Needle-Free Procedure Targeting Deep Facial Muscles and Skin, EMFACE® by BTL Aesthetics Surpasses 1 Million Global Treatments, Drives Rapid Adoption in Singapore's Aesthetic Market

SINGAPORE, June 10, 2025 /PRNewswire/ -- EMFACE® the groundbreaking non-invasive natural facial lifting treatment developed by BTL Aesthetics (BTL), has surpassed 1 million treatments worldwide within the first two years of its introduction. This global milestone is a testament to EMFACE®'s position as the leading non-invasive aesthetic treatment, leveraging breakthrough technology to invent the first needle-free procedure capable of effectively providing deep facial muscle toning and skin tightening for a more lifted and youthful appearance.

Launched in the United States in 2022 and introduced to Singapore in March 2023, the award- winning EMFACE® quickly gained traction among aesthetic practitioners and patients seeking effective non-invasive facial rejuvenation in major markets such as the United States, Europe, Singapore, Japan, Korea and Taiwan.

According to various doctors, the demand for non-invasive aesthetic treatments in Singapore continues to rise due to reduced stigma as aesthetic treatments are increasingly viewed as a form of self-care, as reported by Channel News Asia^[1]. Additionally, The Straits Times^[2] has also highlighted that advancements in technology are providing more convenient solutions with minimal downtime, allowing for more accessible and efficient treatments.

"In recent years, we have seen a major shift in what patients are looking for – effective treatments that deliver natural-looking results without needles, surgery, or extended recovery times. Today's consumers are busy and want options that fit seamlessly into their lifestyles, and non-invasive treatments are answering that call," said Dr. Lynn Chiam, Dermatologist at the Children & Adult Skin Hair Laser Clinic.

Channel News Asia ^[1] has also noted that The Ministry of Health (MOH) reported an average increase of 40 new licensed providers offering aesthetic services between 2020 and 2023. As more individuals seek effective and non-invasive options to achieve their desired appearance, this surge reflects the increasing preference for non-invasive treatments like EMFACE®, with demand expected to grow even further.

To cater to the growing demand for non-invasive aesthetic treatments, EMFACE® effectively targets the facial elevator muscles for a natural lift in just 20 minutes, with no pain and no downtime. Although tangible results can be seen right after the treatments, a minimum of four sessions can deliver truly optimal results. Additionally, a fully personalized treatment plan can be curated by trusted Aesthetic Providers.

EMFACE® is the first device in the market to utilise High-intensity Facial Electrical Stimulation (HIFES) and Synchronized RF technologies. HIFES™ selectively tones the face-elevating muscles to restore and elevate the support of facial features while Synchronized RF heating remodels and smooths the skin by increasing the levels of collagen and elastin fibers. This allows the treatment to penetrate deep into the facial muscles, lifting every layer from muscle to skin, effectively enhancing facial contours from within – a feat previously unattainable with injectables or traditional energy-based devices.

EMFACE® has also expanded its capabilities with the introduction of under-eye applicators, making EMFACE® the only treatment available that addresses the root causes of ageing around the eyes non-invasively by toning muscles and tightening skin. The periorbital area is often the first to show signs of ageing with eyebags, crow's feet, and dark circles. While traditional solutions focus primarily on the skin, the new eye applicators further enhance the treatment's effectiveness by uniquely targeting both the lower part of the orbicularis oculi muscle and delicate skin in the periorbital area.

As the original muscle toning and skin lifting U.S. FDA-cleared treatment, EMFACE® has been recognized for its innovative technology and revolutionary results, having won the 2025 New Beauty Award for 'Best Non-Invasive Facial Sculptor', the 2023 Northern Ireland Cosmetic Medicine Award for 'Innovative Device of the Year', and the 2023 Cosmopolitan Holy Grail Beauty Award for 'Best Treatment Game Changer'.

"BTL Aesthetics is proud of reaching this remarkable milestone which underscores the commitment we have to providing cutting-edge innovative aesthetic solutions. Achieving 1 million EMFACE® treatments globally in under two years highlights the growing consumer demand for non-invasive facial lifting solutions that are painless, require no downtime, and can seamlessly fit into their busy routines," said Mr Ricardo Manaloto, General Manager of BTL Aesthetics.

"We are truly heartened by the trust that our valued partner practitioners have placed in EMFACE®. Their recognition of the role that toning facial muscles plays in facial lifting reinforces its importance as a foundational component of any effective facial lifting treatment. Mr. Manaloto added.

For more information about EMFACE® and the available trusted providers in Singapore, visit BTL Aesthetics Singapore at btlaesthetics.sg/emface/.

About BTL Aesthetics

Founded in 1993, BTL has grown to become one of the world's leading medical equipment manufacturers. With 500+ engineers and 3,000+ employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including intimate health and mental wellness. Among other brands, BTL's products include EMSCULPT NEO®, EMFACE®, EXION™, EMSELLA®, EXOMIND™ as well as their proprietary HIFEM®, HIFES™ and EXOTMS™ procedures.